Patterns, correlates, and prognostic significance of quality of life following breast cancer

被引:21
作者
DiSipio, Tracey [1 ,2 ]
Hayes, Sandi [1 ,2 ]
Battistutta, Diana [2 ]
Newman, Beth [1 ,2 ]
Janda, Monika [1 ,2 ]
机构
[1] Queensland Univ Technol, Sch Publ Hlth, Kelvin Grove, Qld 4059, Australia
[2] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Kelvin Grove, Qld 4059, Australia
基金
澳大利亚国家健康与医学研究理事会;
关键词
breast cancer; oncology; quality of life; survival; PATIENT-REPORTED OUTCOMES; UPPER-BODY FUNCTION; PHYSICAL-ACTIVITY; FUNCTIONAL ASSESSMENT; GENERAL-POPULATION; ONCOLOGY-GROUP; PROSTATE-CANCER; LUNG-CANCER; BASE-LINE; SURVIVAL;
D O I
10.1002/pon.1816
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective: To describe quality of life (QOL) over a 12-month period among women with breast cancer, consider the association between QOL and overall survival (OS), and explore characteristics associated with QOL declines. Methods: A population-based sample of Australian women (n = 287) with invasive, unilateral breast cancer (Stage I+) was observed prospectively for a median of 6.6 years. QOL was assessed at 6, 12, and 18 months post-diagnosis, using the Functional Assessment of Cancer Therapy, Breast (FACT-B+4) questionnaire. Raw scores for the FACT-B+4 and subscales were computed and individuals were categorized according to whether QOL declined, remained stable or improved between 6 and 18 months. Kaplan-Meier and Cox proportional hazards survival methods were used to estimate OS and its associations with QOL. Logistic regression models identified factors associated with QOL decline. Results: Within FACT-B+4 subscales, between 10% and 23% of women showed declines in QOL. Following adjustment for established prognostic factors, emotional well-being and FACT-B+4 scores at 6 months post-diagnosis were associated with OS (p < 0.05). Declines in physical (p < 0.01) or functional (p = 0.02) well-being between 6 and 18 months post-diagnosis were also associated significantly with OS. Receiving multiple forms of adjuvant treatment, a perception of not handling stress well and reporting one or more other major life events at 6 months post-diagnosis were factors associated with declines in QOL in multivariable analyses. Conclusions: Interventions targeted at preventing QOL declines may ultimately improve quantity as well as quality of life following breast cancer. Copyright (C) 2010 John Wiley & Sons, Ltd.
引用
收藏
页码:1084 / 1091
页数:8
相关论文
共 50 条
  • [41] Coping and quality of life of patients following microsurgical treatment for breast cancer-related lymphedema
    Teo, Irene
    Fingeret, Michelle Cororve
    Liu, Jun
    Chang, David W.
    [J]. JOURNAL OF HEALTH PSYCHOLOGY, 2016, 21 (12) : 2983 - 2993
  • [42] Quality of life of breast and cervical cancer survivors
    Huang, Huei-Ying
    Tsai, Wen-Chen
    Chou, Wen-Yu
    Hung, Yao-Ching
    Liu, Liang-Chih
    Huang, Kuo-Feng
    Wang, Wen-Ching
    Leung, Kam-Wing
    Hsieh, Ruey-Kuen
    Kung, Pei-Tseng
    [J]. BMC WOMENS HEALTH, 2017, 17
  • [43] THE SIGNIFICANCE OF NUCLEAR MORPHOMETRIC VARIABLES AS PROGNOSTIC PREDICTORS IN BREAST-CANCER
    AALTOMAA, S
    LIPPONEN, P
    ESKELINEN, M
    KOSMA, VM
    MARIN, S
    ALHAVA, E
    SYRJANEN, K
    [J]. ANTICANCER RESEARCH, 1991, 11 (04) : 1663 - 1669
  • [44] The prognostic significance of Gail model risk factors for women with breast cancer
    Tartter, PI
    Gajdos, C
    Smith, SR
    Estabrook, A
    Rademaker, AW
    [J]. AMERICAN JOURNAL OF SURGERY, 2002, 184 (01) : 11 - 15
  • [45] Clinicopathological and prognostic significance of SDC1 overexpression in breast cancer
    Cui, Xiangrong
    Jing, Xuan
    Yi, Qin
    Long, Chunlan
    Tian, Jie
    Zhu, Jing
    [J]. ONCOTARGET, 2017, 8 (67) : 111444 - 111455
  • [46] Comprehensive Analysis of the Expression and Prognostic Significance of the CENP Family in Breast Cancer
    Liu, Xueliang
    Liu, Yunjiang
    [J]. INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2022, 15 : 3471 - 3482
  • [47] Prognostic Significance of p16 Protein Expression in Breast Cancer
    Salih, Magdi M.
    Higgo, Amjed A.
    Eed, Emad M.
    [J]. IN VIVO, 2022, 36 (01): : 336 - 340
  • [48] Tumor HGF lacks prognostic significance in Mexican breast cancer patients
    Pruefer, F. G.
    Unger-Saldana, K.
    Mohamier, L.
    Ramirez, M.
    Suarez, J.
    Ramirez, M. T.
    Maldonado, V.
    Melendez-Zajgla, J.
    [J]. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2006, 25 (03) : 357 - 364
  • [49] Baseline quality of life and chemotherapy toxicities in patients with early breast cancer
    Licaj, Idlir
    Coquan, Elodie
    Dabakuyo-Yonli, Tienhan Sandrine
    Dauchy, Sarah
    Vaz Luis, Ines
    Charles, Cecile
    Lemogne, Cedric
    Tredan, Olivier
    Vanlemmens, Laurence
    Jouannaud, Christelle
    Levy, Christelle
    Rigal, Olivier
    Fournier, Marion
    Petit, Thierry
    Dalenc, Florence
    Rouanet, Philippe
    Lemonnier, Jerome
    Everhard, Sibille
    Cottu, Paul
    Joly, Florence
    [J]. CANCER, 2023, 129 (07) : 1085 - 1095
  • [50] The effect of melatonin on sleep and quality of life in patients with advanced breast cancer
    Innominato, Pasquale F.
    Lim, Andrew S.
    Palesh, Oxana
    Clemons, Mark
    Trudeau, Maureen
    Eisen, Andrea
    Wang, Cathy
    Kiss, Alex
    Pritchard, Kathleen I.
    Bjarnason, Georg A.
    [J]. SUPPORTIVE CARE IN CANCER, 2016, 24 (03) : 1097 - 1105